Nucleic Acids Res, 2022, 50(6):3056-3069

7,8-Dihydro-8-oxo-1,N6-ethenoadenine: an exclusively Hoogsteen-paired thymine mimic in DNA that induces A→T transversions in Escherichia coli

This work investigated the structural and biological properties of DNA containing 7,8-dihydro-8-oxo-1,N6-ethenoadenine (oxo-ϵA), a non-natural synthetic base that combines structural features of two naturally occurring DNA lesions (7,8-dihydro-8-oxoadenine and 1,N6-ethenoadenine). UV-, CD-, NMR spectroscopies and molecular modeling of DNA duplexes revealed that oxo-ϵA adopts the non-canonical syn conformation (χ = 65º) and fits very well among surrounding residues without inducing major distortions in local helical architecture. The adduct remarkably mimics the natural base thymine. When considered as an adenine-derived DNA lesion, oxo-ϵA was 99% mutagenic in living cells, causing predominantly A→T transversion mutations in Escherichia coli. The adduct in a single-stranded vector was not repaired by base excision repair enzymes (MutM and MutY glycosylases) or the AlkB dioxygenase and did not detectably affect the efficacy of DNA replication in vivo. When the biological and structural data are viewed together, it is likely that the nearly exclusive syn conformation and thymine mimicry of oxo-ϵA defines the selectivity of base pairing in vitro and in vivo, resulting in lesion pairing with A during replication. The base pairing properties of oxo-ϵA, its strong fluorescence and its invisibility to enzymatic repair systems in vivo are features that are sought in novel DNA-based probes and modulators of gene expression.

Aralov AV, Gubina N, Cabrero C, Tsvetkov VB, Turaev AV, Fedeles BI, Croy RG, Isaakova EA, Melnik D, Dukova S, Ryazantsev DY, Khrulev AA, Varizhuk AM, González C, Zatsepin TS, Essigmann JM

IBCH: 9923
Ссылка на статью в журнале: https://academic.oup.com/nar/advance-article/doi/10.1093/nar/gkac148/6541013
Кол-во цитирований на 12.2023: 2
Данные статьи проверены модераторами 2022-03-18

Список научных проектов, где отмечена публикация

  1. R01-CA080024. . Внебюджетное финансирование.
  2. P30-ES002109. . Внебюджетное финансирование.
  3. PID2020-116620GB-I00. . Внебюджетное финансирование.
  4. Разработка средств профилактики и лечения COVID-19 и сопутствующих инфекционных заболеваний с использованием генетических технологий (28 Сентября 2021 года — 31 Декабря 2023 года). Габибов А.Г., Андреев Д.Е., Аралов А.В., Безуглов В.В., Белогуров А.А., Водовозова Е.Л., Звягин А.В., Константинова И.Д., Коршун В.А., Овчинникова Т.В., Рубцов Ю.П., Смирнов И.В., Тоневицкий А.Г.. Договор, Минобрнауки.